Why the Upper Limb Is the 'Forgotten Priority' After Stroke
After a stroke, the upper limb is often the forgotten priority: many patients achieve acceptable ambulation yet remain with a non-functional hand or poorly functioning arm. This limits true functional independence: dressing, feeding, personal hygiene, work and leisure. The problem is typically not 'lack of exercises' but insufficient effective dosing and inadequate transfer to daily living. In 2025, the European Stroke Organisation (ESO) addresses this directly: to change upper limb prognosis, patients require more hours of genuine repetitive practice and a therapeutic design that ensures gains achieved in the clinic translate to the home environment.
Upper Limb Rehabilitation Dosing per ESO 2025: The '20-Hour Rule'
The ESO 2025 guideline states (weak recommendation, very low certainty evidence) that a minimum dose of approximately 20 hours of additional repetitive upper limb practice should be considered to improve arm activity capacity.
- Operational target: Programme a block of 4–6 weeks with 3–5 sessions/week accumulating ≥20 extra hours of quality repetitive practice (not merely 'time in the gym'). Failure to reach this dosing threshold reduces the probability of meaningful functional gains, particularly for hand function.
- Why 20 hours and not 6 or 100?: The guideline acknowledges the precise number is not definitively established, but proposes a pragmatic minimum threshold (≥20 h) consistent with dose-response study findings and the organisational reality of clinical services. It represents an evidence-informed starting point.
Outcome Measurement: Separating 'Capacity' from 'Real-World Use'
If measurement is flawed, optimisation is flawed. The critical distinction is between what the patient can do in the clinic and what they actually do at home.
- Motor impairment: Fugl-Meyer Upper Extremity (FMA-UE): quantifies motor recovery of the arm. The most widely used scale in clinical trials and robotic rehabilitation protocols.
- Activity / capacity: Action Research Arm Test (ARAT): assesses real manual function. Box and Blocks Test: evaluates gross manual dexterity and manipulation speed.
- Real-world use: Motor Activity Log (MAL) or equivalent metrics, ideally supplemented with inertial measurement units (IMUs) for objective real-world arm use measurement outside the clinical setting.
- Key message: Improvement on FMA-UE does not guarantee real-world arm use; therefore, clinicians should measure both capacity (ARAT) and daily life use (MAL/wearable sensors), alongside standard clinical examination.
Transfer Package: The Most Overlooked Component
The ESO 2025 guideline recommends considering behavioural transfer packages to ensure therapeutic gains translate into real-world activities.
- Daily task targets: For example, 30 'functional repetitions': open/close grip, carry a glass, reach into pocket, turn a door handle. These tasks train manual dexterity and fine motor coordination.
- Use contract: 'Use the affected arm in 3 mandatory activities' (eating, hygiene, dressing). This directly combats learned non-use.
- Monitoring and feedback: Simple checklist (morning/afternoon/evening) + weekly photo or video. IMUs or robot repetition counters + therapist report. Objective monitoring sustains adherence.
Upper Limb Robotics: When They Add Real Value
Contemporary evidence converges on a core principle: robotic-assisted therapy can improve upper limb function and activities of daily living (ADLs), particularly by multiplying repetition volume and structuring progression, although effect magnitude and consistency depend on population, stroke phase, severity, and methodological quality.
CIMT and Bilateral Training
Constraint-Induced Movement Therapy (CIMT) and its modified version (mCIMT) restrain the unaffected limb to force use of the paretic arm. It requires a minimum of selective voluntary movement and is ideally combined with an intensive transfer package. Bilateral training engages both upper limbs simultaneously and may serve as an alternative when CIMT is not feasible due to impairment severity.
Expected Timeline for Improvement
If minimum selective movement is present, improvement may begin within 2–4 weeks. If absent, the initial goal is to build capacity (open/close, proximal stability) and prevent learned non-use. The critical point is to measure (ARAT/MAL) rather than relying on subjective 'sensation'.
Evidence Sources
Fuentes
- European Stroke Organisation (ESO): Motor Rehabilitation Guideline 2025 — ≥20 h repetitive upper limb practice recommendation
- Cochrane reviews and guideline updates on upper limb robotics post-stroke
- Dose-response studies in post-stroke upper limb and hand rehabilitation
- Evidence on CIMT/mCIMT and behavioural transfer packages
Request an interdisciplinary assessment and intensive 4–6 week programme design with upper limb robotics, outcome metrics (FMA-UE / ARAT / MAL) and transfer checklist at GNeuro.